Acquirer and marketer of prescription pharmaceutical products to treat pain and related conditions
Based in San Diego, California, Victory Pharma was a pharmaceutical company with a focus in pain and pain-related conditions. EW identified the pain segment within the specialty pharmaceutical market as an attractive one for investment, and made a growth investment into the company in 2009 to fund the continued expansion of Victory’s lead pain product, NAPRELAN, a once-a-day controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID). Shionogi acquired Victory Pharma for $118 million in 2011.
